MondoA Drives Malignancy in cALL through Enhanced Adaptation to Metabolic Stress
A. Sipol, E. Hameister, B. Xue, A. Petry, C. Prexler, M. Barenboim, R. A. Rubio, M. C. Baldauf, D. G. Franchina, J. Schmaeh, G. Richter, G. Cario, T. G. P. Gruenewald, A. Goerlach, D. Brenner, , S. E. G. Burdach
This study shows MondoA promotes malignancy in pediatric cALL by enhancing metabolic stress adaptation, with potential therapeutic implications.
bioRxiv · Nov 1, 2020Cancer Biology